Business Wire

Cumulocity, and its Strategic Partner Deutsche Telekom, Simplify Industry 4.0 Deployments with its Unique Cloud Field Bus Solution

Del

Cumulocity’s Cloud Field Bus solution fundamentally simplifies the real-world concerns of customers connecting their “machines” in an easy and productive way. There is neither a lengthy integration process nor special training required to connect “machines”.

Cumulocity’s unique Cloud Field Bus solution allows users to connect their machines in minutes. With Cloud Field Bus the machine securely registers itself to the Cumulocity platform at power up over any communication connection and allows the Cumulocity platform to assign a predefined data model and protocol configuration.

This means that Industrial IoT deployment and operations costs are dramatically reduced through the use of much cheaper IoT modems, commodity communications and increased automation in the deployment process; at the same time the security protection is increasing to A+ carrier grade. It also drastically improves the efficiency of the operations and maintenance of IoT deployments as it allows the field service teams to replace a faulty IoT modem with virtually any other modem they have in their van.

Deutsche Telekom launched the ‘Cloud of Things’, powered by Cumulocity, in spring 2015 and recently launched the Cloud Field Bus with Modbus TCP support.

Cloud Field Bus modems are already available from a range of manufacturers and Cumulocity’s open approach allows virtually any compatible IoT device to be used as a Field Bus modem.

“The Deutsche Telekom ‘Cloud of Things’ offering was developed in close collaboration with Cumulocity. The Cloud Field Bus extension has already captured the interest of many customers and first commercial deployments are happening. The solution removed many concerns about the perceived overheads for IoT deployments and allows our customer’s equipment to be connected in minutes.”, stated Dr Alexander Lautz, Senior Vice Preisdent M2M at Deutsche Telekom.

“With today’s announcement we improve the simplification of connecting and operating industrial machines including compressors, air conditioning units, trucks, heavy equipment vehicles, pumps, sewing machines etc. Once the machines are connected the wider business benefits can be securely created including cost reductions from field force automation, increased customer satisfaction through predictive maintenance and introductions of new business models. At Cumulocity we strive to remove complexity and costs so that the benefits of IoT to be exploited rapidly, comprehensively and securely by all organisations.”, explained Bernd Gross, CEO of Cumulocity.

About Telekom ‘Cloud of Things’ – powered by Cumulocity

With Deutsche Telekom’s Cloud of Things, machinery manufacturers and operators can monitor and manage their machinery and equipment more easily. Data analytics and device management via the cloud enables companies to provide greatly improved automation and service that is managed remotely. Use cases include remote management and control, condition monitoring, predictive maintenance and big data streaming analytics.

http://m2m.telekom.com/our-offering/cloud-of-things/

About Cumulocity

Cumulocity is the leading independent Application and Device Management platform for the Internet-of-Things (IoT) since 2010. Cumulocity is an open platform that provides a complete feature set for rapidly deploying IoT solutions. The key features include Data collection and Storage, Big Data Streaming Analytics, Real-Time Visualization and Automation as well as IoT Device Management. Our open and publicly documented APIs and the open UI framework, enable our partners and customers to configure and extend the platform to their unique needs.

Scalability, security and reliability are critical in IoT solutions and our origins as part of Nokia Siemens Networks, the world's mobile broadband specialist, gives us the experience of securely managing millions of devices without service interruptions. Cumulocity can be deployed in a Cloud and On-Premise and enables enterprises to start small and scale out to millions of devices with the deployment model fit for their business. Today Cumulocity software is operated in more than 20 data centers across 5 continents.

Contact information

Cumulocity
Philip Hooker
E-mail: mediarelations@cumulocity.com
http://www.cumulocity.com
Phone: +49 (211) 74951433

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease18.7.2018 21:45Pressemelding

VIEW E-MEDIA KIT – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which supported the FDA approval in July 2017 to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older. The article reports results that showed significantly fewer sickle cell crises in those receiving Endari compared to placebo by 25 percent; p=0.005 (median 3 vs. median 4) and significantly fewer hospitalizations by 33 percent; p=0.005 (median 2 vs. median 3). Additional findings showed lower cumulative days in hospital of 41 percent; p=0.02 (median 6.5 days vs. median 11 days) and a lower incidence of acute chest syndrome (ACS) by more than 60 percent; p=0.003 (13 of 152 patients [8.6%] had at least 1 ACS compared with 18 of 78 in the placebo group [23.1%]). The most common adverse reactions, occurring in great

Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform18.7.2018 19:41Pressemelding

Tigo®, pioneer of the smart modular Flex MLPE platform, today announced the release of its new Mesh communication architecture. This state-of-the-art wireless technology directly translates to customer benefits – including simplifying the solar design process and accelerating the commissioning steps. The complete Tigo solution uses a simple yet powerful data collection technology that covers the widest ranges of residential & commercial installations at the lowest cost. With Mesh and the recently announced Tigo Access Point (TAP), customers eliminate the need to address any roof obstruction or orientation constraint. To learn more about Mesh and TAP, register for Tigo’s free, online webinar “The Future of Solar is Wireless” on Wednesday July 25th, 2018 at 10am PDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180718005827/en/ Mesh is Tigo's proprietary software that allows each TS4 unit to act as a repeater, extending the

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 17:21Pressemelding

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 16:00Pressemelding

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 12:38Pressemelding

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 12:05Pressemelding

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d